In a recent global trial, Velocity sites enrolled participants 50% faster than the average trial site. Additionally, Velocity supported the trial with over 30 research sites across several countries. In another recent trial, Velocity’s 20 sites outpaced average trial site enrollment rate by nearly 80%.
These achievements illustrate the power of Velocity at Scale — the ability to enroll a proportionately greater number of participants, faster.
Discover more about our integrated recruitment and retention approach, as well as VISION, our AI-enabled platform refining data on over 1.5 million patients worldwide: https://velocityclinical.com/patient-recruitment/https://lnkd.in/g6rJSFh2
